The Board resolution dated February 25, 2021, the Board of Directors of Imexpharm Corporation approved the holding of Annual General Meeting 2021 as follows:

-          Record date: March 22, 2021

-          Meeting time:  expected at 8:00, April 24, 2021

-          Meeting venue: Notice later.

-          Content:

• Report on the BOD activities in 2020 and plan for 2021;
• Report from the Supervisory Board in 2020;
• Audited financial statements in 2020;
• Plan for profit distribution and dividend payment in 2020;
• Remuneration of the BOD and Supervisory Board in 2020 and plan for 2021;
• Selection of the auditor for the financial statements in 2021;
• Other issues.